# EDGAR Filing Document

**Accession Number:** 0001857475
**File Stem:** 0001857475-26-000049
**Filing Date:** 2026-5
**Character Count:** 58362
**Document Hash:** e87d8cb6b41aef868a877739c0e0639b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001857475-26-000049.hdr.sgml**: 20260511

**ACCESSION NUMBER**: 0001857475-26-000049

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260511

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260511

**DATE AS OF CHANGE**: 20260511

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dole plc
- **CENTRAL INDEX KEY:** 0001857475
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE PRODUCTION - CROPS [0100]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40695
- **FILM NUMBER:** 26960658

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 29 NORTH ANNE STREET
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 353 1 88 72745

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 29 NORTH ANNE STREET
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dole Ltd
- **DATE OF NAME CHANGE:** 20210416

?xml version='1.0' encoding='ASCII'? dole-20260511

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event Reported): May 11, 2026**

**Dole plc**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **Ireland** | **001-40695** | &nbsp;&nbsp;&nbsp;&nbsp;**98-1610692** |
| **(State or other jurisdiction &nbsp;&nbsp;&nbsp;&nbsp;**<br>**&nbsp;&nbsp;&nbsp;&nbsp; of incorporation)**  | **(Commission File Number)&nbsp;&nbsp;&nbsp;&nbsp;** | **(I.R.S. Employer Identification No.)**  |

---

**29 North Anne Street, Dublin 7**

**D07 PH36 Ireland**

**101 South Tryon St, Suite 600, Charlotte, NC**

**United States 28280** 

(Address of Principal Executive Offices)

Registrant's telephone number, including area code: **353-1-887-2600**

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol (s)** | **Name of each exchange on which registered** |
| Ordinary Shares, $0.01 Par Value Per Share | DOLE | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On May 11, 2026, Dole plc (the "Company") issued a press release disclosing its financial results for the three months ended March 31, 2026. A copy of the press release is attached to this Current Form on 8-K as Exhibit 99.1.

**Item 7.01. Regulation FD Disclosure.**

At 08:00 a.m. Eastern Time on May 11, 2026, the Company will host a conference call and simultaneous webcast to discuss its financial results for the three months ended March 31, 2026. An archived replay of the webcast and the investor presentation used during the webcast will be available shortly after the live event has concluded in the Investors section of the Company's website, www.doleplc.com/investors.

The information being furnished pursuant to Item 2.02, including Exhibit 99.1, and Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liability of that section, and shall not be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

**(d) Exhibits**

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| 99.1 | <u>[Dole plc Press Release issued May 11, 202](doleplcreportsfirstquarter.htm)[6](doleplcreportsfirstquarter.htm)[– Dole plc Reports First Quarter 2026 Financial Results](doleplcreportsfirstquarter.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

DOLE PLC

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Date: May 11, 2026 | **DOLE PLC**<br>(Registrant) |
|  | By: /s/ Jacinta Devine |
|  | Name: Jacinta Devine |
|  | Title: Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**Dole plc Reports First Quarter 2026 Financial Results** 

DUBLIN – May 11, 2026 - Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three months ended March 31, 2026.

**First Quarter Highlights:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Solid start to the year: 11.6% revenue growth reflecting positive momentum across the Group

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Robust consumer demand across our key markets, supported by evolving dietary preferences, GLP-1 adoption, and broader health and wellness trends

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strong performance in Diversified Fresh Produce - Americas & ROW and growth in Diversified Fresh Produce - EMEA partially offsetting lower result in Fresh Fruit

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Income of $37.7 million and Diluted EPS of $0.33

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>1</sup> of $100.3 million; in line with our expectations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Net Income<sup>1</sup> of $31.2 million and Adjusted Diluted EPS<sup>1</sup> of $0.33

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Post quarter end, regulatory approval received for sale of port in Ecuador; completion expected before end of second quarter

**Financial Highlights**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
|  | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* |
| Revenue | 2342  | 2099  |
| Net Income | 37.7  | 44.2  |
| Net Income attributable to Dole plc | 31.3  | 38.9  |
| Diluted EPS | 0.33  | 0.41  |
| Adjusted EBITDA<sup>1</sup> | 100.3  | 104.8  |
| Adjusted Net Income<sup>1</sup> | 31.2  | 33.1  |
| Adjusted Diluted EPS<sup>1</sup> | 0.33  | 0.35  |

---

Commenting on the results, Carl McCann, Executive Chairman, said:

*"We are pleased with our solid start to the year. Robust consumer demand in our key markets is driving revenue growth and contributing to positive momentum across the Group.*

*While we are experiencing complexity in the operating environment due to the ongoing conflict in the Middle East, we believe the strength of our broad and resilient business model positions us well to manage these evolving conditions.*

*We continue to target full year Adjusted EBITDA of at least $400 million."*

**Group Results - First Quarter**

Revenue increased 11.6%, or $242.8 million, primarily due to positive operational performance across all segments, mainly due to higher worldwide pricing in Fresh Fruit, and a favorable impact from foreign currency translation of $96.2 million. On a like-for-like basis<sup>2</sup>, revenue increased 7.0%, or $146.6 million.

Gross Profit increased $2.8 million, primarily due to higher revenue, partially offset by higher cost of sales which were impacted by higher fruit sourcing costs in the Fresh Fruit segment.

Operating Income decreased $5.9 million primarily due to higher SMG&A expenses and higher gains on asset sales in the prior year following the sale of land in Hawaii.

------

Net Income decreased to $37.7 million from $44.2 million in the prior year. This decrease was due to lower Operating Income, higher tax charges and lower equity method earnings, as the prior year included the benefit of a non-cash gain of $6.9 million on a M&A transaction relating to an equity method investment. These decreases were partially offset by an increase in other income due primarily to fair value adjustments of financial instruments and lower interest expense.

Adjusted EBITDA decreased 4.3%, or $4.5 million, primarily driven by higher fruit sourcing costs in the Fresh Fruit segment, partially offset by good performance in the Diversified Fresh Produce - Americas & ROW segment, as well as a favorable impact of foreign currency translation of $3.2 million.

Adjusted Net Income decreased 5.8%, or $1.9 million, predominantly due to the decrease in Adjusted EBITDA noted above and higher depreciation expense, partially offset by lower interest expense. Adjusted Diluted EPS for the three months ended March 31, 2026 was $0.33 compared to $0.35 in the prior year.

**Selected Segmental Financial Information**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** |
|  | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* |
|  | **Revenue** | **Adjusted EBITDA**<sup>1</sup> | **Revenue** | **Adjusted EBITDA**<sup>1</sup> |
| Fresh Fruit | $937660  | $52553  | $878145  | $63331  |
| Diversified Fresh Produce - EMEA | 1022324  | 29965  | 892087  | 27660  |
| Diversified Fresh Produce - Americas & ROW | 420011  | 17794  | 363413  | 13831  |
| Intersegment | (37820) | —  | (34241) | —  |
| **Total** | $**2342175**  | $**100312**  | $**2099404**  | $**104822**  |

---

**First Quarter Segmental Commentary**

***Fresh Fruit***

Revenue increased 6.8%, or $59.5 million, primarily due to higher worldwide pricing of bananas, pineapples and plantains and higher volumes of bananas sold in Europe.

Adjusted EBITDA decreased 17.0%, or $10.8 million, primarily driven by higher fruit costs in bananas due to higher overall sourcing costs in the market and higher fruit sourcing costs in pineapples, particularly due to the strengthening of the Costa Rican Colón against the U.S. Dollar.

***Diversified Fresh Produce – EMEA***

Revenue increased 14.6%, or $130.2 million, primarily due to a favorable impact from foreign currency translation of $94.6 million, as a result of the strengthening of the Swedish krona, Euro and British pound against the U.S. Dollar, as well as underlying growth in France and Germany. On a like-for-like basis, revenue increased 4.0%, or $35.7 million.

Adjusted EBITDA increased 8.3%, or $2.3 million, primarily due to a favorable impact from foreign currency translation of $3.7 million, as well as strong performance in Scandinavia and Germany. These increases were partially offset by weaker performance in South Africa, the U.K. and the Netherlands. On a like-for-like basis, Adjusted EBITDA decreased 5.1%, or $1.4 million.

***Diversified Fresh Produce – Americas & ROW***

Revenue increased 15.6%, or $56.6 million, primarily driven by higher volumes and positive pricing in our southern hemisphere export business, as well as higher volumes in our North America import and marketing businesses, offsetting lower pricing, primarily in avocados.

------

Adjusted EBITDA increased 28.7%, or $4.0 million, driven by a positive impact in our southern hemisphere export business, a good performance in our North America import and marketing businesses, in part supported by the benefit of a partial restructuring of our operations in the fourth quarter of 2025, as well as good performance in our joint ventures operations.

**Capital Expenditures**

Cash capital expenditures from continuing operations for the three months ended March 31, 2026 were $17.8 million. Expenditures included farming investments, investments in warehouse ripening rooms in France and the U.K., as well as other machinery and equipment related to blueberry and avocado packing in Europe.

**Free Cash Flow from Continuing Operations, Net Debt and Net Leverage**

Free cash flow from continuing operations was an outflow of $40.2 million for the three months ended March 31, 2026, compared to an outflow of $131.6 million in the prior year. The improvement in free cash flow was due to lower seasonal working capital outflows and lower capital expenditures in the current year. Net Debt and Net Leverage as of March 31, 2026 was $657.1 million and 1.7x, respectively.

**Dividend**

On May 8, 2026, the Board of Directors of Dole plc declared a cash dividend for the first quarter of 2026 of $0.085 per share, payable on July 8, 2026 to shareholders of record on June 17, 2026. A cash dividend of $0.085 per share was paid on April 8, 2026 for the fourth quarter of 2025.

**Share Repurchase Program**

During the quarter, we repurchased 306,570 shares at an average price of $15.13 per share, totaling $4.6 million. $95.4 million remained available for repurchase under the share repurchase program.

**Outlook for Fiscal Year 2026 (forward-looking statement)**

We are pleased with the solid start to the year and the positive momentum we are seeing across our operations.

Conditions in the Middle East continue to evolve, resulting in a more complex operating environment and directly impacting on our cost base. We anticipate increased shipping and fuel costs in the second quarter, particularly in our Fresh Fruit segment. However, as the year progresses, we expect to see the benefit of contract price adjustments, as well as the benefit of our dynamic pricing strategy in our diversified divisions, coming through.

We believe that our resilient and diversified business model positions us well to handle today's complex environment. Alongside this, demand for our products remains strong, supported by prevailing health and wellness trends. We also anticipate positive returns from our recent investments and remain committed to advancing our development pipeline.

Considering all relevant factors, we are maintaining our target of a full-year Adjusted EBITDA of at least $400 million for 2026.

We are maintaining our guidance for routine capex of approximately $100 million. In addition, we continue to explore a range of development opportunities which, if executed, will strengthen our business and continue to drive further growth in the years to come.

We are reducing our full year interest expense guidance by $2 million to approximately $58 million.

**Footnote Index**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Refer to the Appendix of this release for an explanation and reconciliation of non-GAAP financial measures used in this release to comparable GAAP financial measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Like-for-like basis refers to the measure excluding the impact of foreign currency translation movements and acquisition and divestitures. Refer to the Appendix and "Supplementary Reconciliation of Prior Year Segment

------

Results to Current Year Segment Results" for further detail on these impacts and the calculation of like-for-like basis variances

**About Dole plc**

A global leader in fresh produce, Dole plc produces, markets, and distributes an extensive variety of fresh fruits and vegetables sourced locally and from around the world. Dedicated and passionate in exceeding our customers' requirements in over 85 countries, our goal is to make the world a healthier and a more sustainable place.

**Webcast and Conference Call Information**

Dole plc will host a conference call and simultaneous webcast at 08:00 a.m. Eastern Time today to discuss the first quarter 2026 financial results. The webcast can be accessed at www.doleplc.com/investor-relations or directly at

https://events.q4inc.com/attendee/539437681.

**Forward-looking information**

Certain statements made in this press release that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on management's beliefs, assumptions, and expectations of our future economic performance, considering the information currently available to management. These statements are not statements of historical fact. The words "believe," "may," "could," "will," "should," "would," "anticipate," "estimate," "expect," "intend," "objective," "seek," "strive," "target" or similar words, or the negative of these words, identify forward-looking statements. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made except as required by the federal securities laws.

**Investor Contact:**

James O'Regan, Head of Investor Relations, Dole plc

*<u>james.oregan@doleplc.com</u>* 

+353 1 887 2794

**Media Contact:**

Brian Bell, Ogilvy

*<u>brian.bell@ogilvy.com</u>* 

+353 87 2436 130

------

**Appendix**

**Condensed Consolidated Statements of Operations - Unaudited**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
|  | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* |
| Revenues, net | $2342175  | $2099404  |
| Cost of sales | (2157182) | (1917211) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 184993  | 182193  |
| Selling, marketing, general and administrative expenses | (123780) | (118412) |
| Gain on disposal of businesses | 1192  | 361  |
| Gain on asset sales | 667  | 3801  |
| Impairment and asset write-downs of property, plant and equipment and lease assets | (1112) | (38) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income | 61960  | 67905  |
| Other income (expense), net | 4538  | (348) |
| Interest income | 4205  | 3040  |
| Interest expense | (12586) | (17182) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before income taxes and equity earnings | 58117  | 53415  |
| Income tax expense  | (21982) | (17578) |
| Equity method earnings | 1600  | 8292  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations  | 37735  | 44129  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from discontinued operations, net of income taxes | —  | 30  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 37735  | 44159  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income attributable to noncontrolling interests | (6438) | (5247) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Dole plc | $31297  | $38912  |
| Income per share - basic: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $0.33  | $0.41  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | —  | —  |
| Net income per share attributable to Dole plc - basic | $0.33  | $0.41  |
| Income per share - diluted: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $0.33  | $0.41  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | —  | —  |
| Net income per share attributable to Dole plc - diluted | $0.33  | $0.41  |
| Weighted-average shares: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 95168  | 95109  |
| &nbsp;&nbsp;&nbsp;Diluted | 95758  | 95677  |

---

------

**Condensed Consolidated Balance Sheets - Unaudited**

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| **ASSETS** | *(U.S. Dollars and shares in thousands)* | *(U.S. Dollars and shares in thousands)* |
| Cash and cash equivalents | $273168  | $267854  |
| Short-term investments | 6721  | 6418  |
| Trade receivables, net of allowances for credit losses of $21,028 and $20,558, respectively | 592602  | 539840  |
| Grower advance receivables, net of allowances of $36,715 and $37,915, respectively | 122957  | 143426  |
| Other receivables, net of allowances of $17,131 and $17,027, respectively | 130483  | 121355  |
| Inventories, net of allowances of $3,506 and $3,659, respectively | 490825  | 509260  |
| Prepaid expenses | 77960  | 70007  |
| Other current assets | 16598  | 17891  |
| Assets held for sale | 78506  | 75689  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1789820  | 1751740  |
| Long-term investments  | 13330  | 13827  |
| Investments in unconsolidated affiliates | 140788  | 142082  |
| Actively marketed property | 53231  | 53231  |
| Property, plant and equipment, net of accumulated depreciation of $619,739 and $619,706, respectively | 1057452  | 1081656  |
| Operating lease right-of-use assets | 404388  | 371366  |
| Goodwill | 431329  | 434345  |
| DOLE® brand | 306280  | 306280  |
| Other intangible assets, net of accumulated amortization of $133,304 and $133,022, respectively | 17371  | 18997  |
| Other assets | 142018  | 133931  |
| Deferred tax assets, net | 93059  | 88669  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $4449066  | $4396124  |
| **LIABILITIES AND EQUITY** |  |  |
| Accounts payable | $702770  | $712483  |
| Income taxes payable | 27191  | 21805  |
| Accrued liabilities | 477705  | 517989  |
| Bank overdrafts | 12696  | 9611  |
| Current portion of long-term debt, net | 40633  | 57668  |
| Current maturities of operating leases | 78501  | 71379  |
| Payroll and other tax | 37256  | 36320  |
| Contingent consideration | 3734  | 3252  |
| Pension and other postretirement benefits | 18552  | 18699  |
| Liabilities held for sale | 16331  | 14047  |
| Dividends payable and other current liabilities | 16064  | 31228  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1431433  | 1494481  |
| Long-term debt, net | 870176  | 799814  |
| Operating leases, less current maturities | 331951  | 306566  |
| Deferred tax liabilities, net | 94770  | 90100  |
| Contingent consideration, less current portion | 889  | 500  |
| Pension and other postretirement benefits, less current portion | 133010  | 135900  |
| Other long-term liabilities | 67956  | 66990  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $2930185  | $2894351  |
| Redeemable noncontrolling interests | 31917  | 29716  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock — $0.01 par value; 300,000 shares authorized; 95,158 and 95,163 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 955  | 952  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 798607  | 804247  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 699467  | 676371  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (122992) | (117467) |
| Total equity attributable to Dole plc | 1376037  | 1364103  |
| Equity attributable to noncontrolling interests | 110927  | 107954  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 1486964  | 1472057  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, redeemable noncontrolling interests and equity | $4449066  | $4396124  |

---

------

**Condensed Consolidated Statements of Cash Flows - Unaudited**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
| **Operating Activities** | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| &nbsp;&nbsp;&nbsp;Net income | $37735  | $44159  |
| &nbsp;&nbsp;&nbsp;Income from discontinued operations, net of taxes | —  | (30) |
| &nbsp;&nbsp;&nbsp;Income from continuing operations | 37735  | 44129  |
| Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 28068  | 26544  |
| &nbsp;&nbsp;&nbsp;Impairment and asset write-downs of property, plant and equipment and lease assets | 1112  | 38  |
| &nbsp;&nbsp;&nbsp;Net gain on sale of assets | (667) | (3801) |
| &nbsp;&nbsp;&nbsp;Net gain on sale of businesses | (1192) | (361) |
| &nbsp;&nbsp;&nbsp;Net (gain) loss on financial instruments | (6128) | 4822  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | 1538  | 1447  |
| &nbsp;&nbsp;&nbsp;Equity method earnings | (1600) | (8292) |
| &nbsp;&nbsp;&nbsp;Amortization of debt discounts and debt issuance costs | 786  | 1290  |
| &nbsp;&nbsp;&nbsp;Deferred tax benefit | (1269) | (516) |
| &nbsp;&nbsp;&nbsp;Pension and other postretirement benefit plan cost | 2142  | 1364  |
| &nbsp;&nbsp;&nbsp;Dividends received from equity method investments | 2114  | 197  |
| &nbsp;&nbsp;&nbsp;Gain on insurance proceeds | —  | (1407) |
| &nbsp;&nbsp;&nbsp;Other | 10  | (1365) |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Receivables, net of allowances | (43266) | (144356) |
| &nbsp;&nbsp;&nbsp;Inventories | 16539  | 1420  |
| &nbsp;&nbsp;&nbsp;Prepaids, other current assets and other assets | (16664) | (1745) |
| &nbsp;&nbsp;&nbsp;Accounts payable, accrued liabilities and other liabilities | (41725) | 1803  |
| Net cash used in operating activities - continuing operations | (22467) | (78789) |
| **Investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Sales of assets | 1644  | 4824  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | (17758) | (52836) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of businesses, net of transaction costs and cash transferred | 4968  | 361  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds | —  | 15826  |
| &nbsp;&nbsp;&nbsp;Net sales of unconsolidated affiliates | 223  | —  |
| &nbsp;&nbsp;&nbsp;Other | 85  | (13) |
| Net cash used in investing activities - continuing operations | (10838) | (31838) |
| **Financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from borrowings and overdrafts | 462060  | 312077  |
| &nbsp;&nbsp;&nbsp;Repayments on borrowings and overdrafts  | (403176) | (248815) |
| &nbsp;&nbsp;&nbsp;Dividends paid to shareholders | (8599) | (7765) |
| &nbsp;&nbsp;&nbsp;Dividends paid to noncontrolling interests | (2042) | (2192) |
| &nbsp;&nbsp;&nbsp;Repurchases of Ordinary shares | (4644) | —  |
| &nbsp;&nbsp;&nbsp;Tax payments for net settlement of share-based payments | (3116) | —  |
| &nbsp;&nbsp;&nbsp;Payment of contingent consideration | —  | (38) |
| Net cash provided by financing activities - continuing operations | 40483  | 53267  |
| Effect of foreign exchange rate changes on cash | (1864) | 5954  |
| Net cash used in operating activities - discontinued operations | —  | (22054) |
| Net cash used in investing activities - discontinued operations | —  | (1737) |
| Cash used in discontinued operations, net | —  | (23791) |
| Increase (decrease) in cash and cash equivalents | 5314  | (75197) |
| Cash and cash equivalents at beginning of period, including discontinued operations | 267854  | 331719  |
| Cash and cash equivalents at end of period, including discontinued operations | $273168  | $256522  |
| **Supplemental cash flow information:** |  |  |
| Income tax payments, net of refunds | $(12935) | $(9465) |
| Interest payments on borrowings | $(13736) | $(16657) |

---

------

**Reconciliation from Net Income to Adjusted EBITDA - Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| **Net income (Reported GAAP)** | $**37735**  | $**44159**  |
| &nbsp;&nbsp;&nbsp;Income from discontinued operations, net of income taxes | —  | (30) |
| **Income from continuing operations (Reported GAAP)** | **37735**  | **44129**  |
| &nbsp;&nbsp;&nbsp;Income tax expense  | 21982  | 17578  |
| &nbsp;&nbsp;&nbsp;Interest expense | 12586  | 17182  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (4125) | 5916  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (47) | (2441) |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (1192) | (361) |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 912  | —  |
| &nbsp;&nbsp;&nbsp;Other items<sup>1</sup> | (12) | 94  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | 1755  | (5712) |
| **Adjusted EBIT (Non-GAAP)** | **69594**  | **76385**  |
| &nbsp;&nbsp;&nbsp;Depreciation | 26527  | 24813  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1541  | 1731  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization adjustments from equity method investments | 2650  | 1893  |
| **Adjusted EBITDA (Non-GAAP)** | $**100312**  | $**104822**  |

---

<sup>1</sup> For the three months ended March 31, 2026, other items is primarily comprised of $0.9 million of interest income on deferred transaction consideration, partially offset by $0.9 million of acquisition and transaction costs. For the three months ended March 31, 2025, other items is primarily comprised of $0.1 million of costs for legal matters.

------

**Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item. Refer to the following pages for supplementary reconciliations on these items.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
|  | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* |
| **Net income attributable to Dole plc (Reported GAAP)** | $**31297**  | $**38912**  |
| &nbsp;&nbsp;&nbsp;Income from discontinued operations, net of income taxes | —  | (30) |
| **Income from continuing operations attributable to Dole plc**  | **31297**  | **38882**  |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1541  | 1731  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (4125) | 5916  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (47) | (2441) |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (1192) | (361) |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 912  | —  |
| &nbsp;&nbsp;&nbsp;Other items<sup>2</sup> | 900  | 94  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | 64  | (7444) |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | 2178  | (1941) |
| &nbsp;&nbsp;&nbsp;NCI impact of items above | (354) | (1360) |
| **Adjusted Net Income for Adjusted EPS calculation (Non-GAAP)** | $**31174**  | $**33076**  |
| Adjusted earnings per share – basic (Non-GAAP) | $0.33  | $0.35  |
| Adjusted earnings per share – diluted (Non-GAAP) | $0.33  | $0.35  |
| Weighted average shares outstanding – basic | 95168  | 95109  |
| Weighted average shares outstanding – diluted | 95758  | 95677  |

---

&nbsp;&nbsp;&nbsp;&nbsp;

<sup>2</sup> For the three months ended March 31, 2026, other items is primarily comprised of $0.9 million of acquisition and transaction costs. For the three months ended March 31, 2025, other items is primarily comprised of $0.1 million of costs for legal matters.

------

**Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* |
| | **Revenues, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administrative expenses** | **Other operating items<sup>3</sup>** | **Operating Income** |
| **Reported (GAAP)** | $**2342175**  | **(2157182)** | **184993**  | ***7.9*** <br>*%*** | **(123780)** | **747**  | $**61960**  |
| Income from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |
| Amortization of intangible assets | —  | —  | —  |  | 1541  | —  | 1541  |
| Mark to market (gains) losses | —  | 191  | 191  |  | —  | —  | 191  |
| Gain on asset sales | —  | —  | —  |  | —  | (47) | (47) |
| Gain on disposal of businesses | —  | —  | —  |  | —  | (1192) | (1192) |
| Impairment of property, plant and equipment and lease assets | —  | —  | —  |  | —  | 912  | 912  |
| Other items | —  | —  | —  |  | 25  | —  | 25  |
| Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |
| Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |
| NCI impact of items above | —  | —  | —  |  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**2342175**  | **(2156991)** | **185184**  | ***7.9*** <br>*%*** | **(122214)** | **420**  | $**63390**  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* |
| | **Revenues, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administrative expenses** | **Other operating items**<sup>4</sup> | **Operating Income** |
| **Reported (GAAP)** | $**2099404**  | **(1917211)** | **182193**  | ***8.7*** <br>*%*** | **(118412)** | **4124**  | $**67905**  |
| Income from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |
| Amortization of intangible assets | —  | —  | —  |  | 1731  | —  | 1731  |
| Mark to market (gains) losses | —  | 200  | 200  |  | —  | —  | 200  |
| Gain on asset sales | —  | —  | —  |  | —  | (2441) | (2441) |
| Gain on disposal of businesses | —  | —  | —  |  | —  | (361) | (361) |
| Other items | —  | —  | —  |  | 94  | —  | 94  |
| Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |
| Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |
| NCI impact of items above | —  | —  | —  |  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**2099404**  | **(1917011)** | **182393**  | ***8.7*** <br>*%*** | **(116587)** | **1322**  | $**67128**  |

---

<sup>3</sup> Other operating items for the three months ended March 31, 2026 is comprised of a $1.2 million gain on disposal of businesses and a $0.7 million gain on asset sales, offset partially by $0.9 million of impairment charges and asset write-downs of property, plant and equipment and lease assets, as reported on the Dole plc GAAP Condensed Consolidated Statements of Operations.

<sup>4</sup> Other operating items for the three months ended March 31, 2025 is comprised of a $0.4 million gain on disposal of businesses and a $3.8 million gain on asset sales, offset partially by other immaterial activity, as reported on the Dole plc GAAP Condensed Consolidated Statements of Operations.

------

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity method earnings** | **Income from continuing operations** | **Income from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**4538**  | **4205**  | **(12586)** | **(21982)** | **1600**  | **37735**  | **—**  |
| Income from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | —  |
| Amortization of intangible assets | —  | —  | —  | —  | —  | 1541  | —  |
| Mark to market (gains) losses | (4316) | —  | —  | —  | —  | (4125) | —  |
| Gain on asset sales | —  | —  | —  | —  | —  | (47) | —  |
| Gain on disposal of businesses | —  | —  | —  | —  | —  | (1192) | —  |
| Impairment of property, plant and equipment and lease assets | —  | —  | —  | —  | —  | 912  | —  |
| Other items | 875  | —  | —  | —  | —  | 900  | —  |
| Adjustments from equity method investments | —  | —  | —  | —  | 64  | 64  | —  |
| Income tax on items above and discrete tax items | —  | —  | —  | 2194  | (16) | 2178  | —  |
| NCI impact of items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**1097**  | **4205**  | **(12586)** | **(19788)** | **1648**  | **37966**  | $**—**  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity method earnings** | **Income from continuing operations** | **Income from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**(348)** | **3040**  | **(17182)** | **(17578)** | **8292**  | **44129**  | **30**  |
| Income from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | (30) |
| Amortization of intangible assets | —  | —  | —  | —  | —  | 1731  | —  |
| Mark to market (gains) losses | 5716  | —  | —  | —  | —  | 5916  | —  |
| Gain on asset sales | —  | —  | —  | —  | —  | (2441) | —  |
| Gain on disposal of businesses | —  | —  | —  | —  | —  | (361) | —  |
| Other items | —  | —  | —  | —  | —  | 94  | —  |
| Adjustments from equity method investments | —  | —  | —  | —  | (7444) | (7444) | —  |
| Income tax on items above and discrete tax items | —  | —  | —  | (1869) | (72) | (1941) | —  |
| NCI impact of items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**5368**  | **3040**  | **(17182)** | **(19447)** | **776**  | **39683**  | $**—**  |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2026**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Net income** | **Net income attributable to noncontrolling interests** | **Net income attributable to Dole plc** | **Diluted net income per share** |  |
| **Reported (GAAP)** | $**37735**  | $**(6438)** | $**31297**  | $**0.33**  |  |
| Income from discontinued operations, net of income taxes | —  | —  | —  |  |  |
| Amortization of intangible assets | 1541  | —  | 1541  |  |  |
| Mark to market (gains) losses | (4125) | —  | (4125) |  |  |
| Gain on asset sales | (47) | —  | (47) |  |  |
| Gain on disposal of businesses | (1192) | —  | (1192) |  |  |
| Impairment of property, plant and equipment and lease assets | 912  | —  | 912  |  |  |
| Other items | 900  | —  | 900  |  |  |
| Adjustments from equity method investments | 64  | —  | 64  |  |  |
| Income tax on items above and discrete tax items | 2178  | —  | 2178  |  |  |
| NCI impact of items above | —  | (354) | (354) |  |  |
| **Adjusted (Non-GAAP)** | $**37966**  | $**(6792)** | $**31174**  |  | $**0.33**  |
| **Weighted average shares outstanding – diluted** |  |  | 95758  |  |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended March 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Net income** | **Net income attributable to noncontrolling interests** | **Net income attributable to Dole plc** | **Diluted net income per share** |  |
| **Reported (GAAP)** | $**44159**  | $**(5247)** | $**38912**  | $**0.41**  |  |
| Income from discontinued operations, net of income taxes | (30) | —  | (30) |  |  |
| Amortization of intangible assets | 1731  | —  | 1731  |  |  |
| Mark to market (gains) losses | 5916  | —  | 5916  |  |  |
| Gain on asset sales | (2441) | —  | (2441) |  |  |
| Gain on disposal of businesses | (361) | —  | (361) |  |  |
| Other items | 94  | —  | 94  |  |  |
| Adjustments from equity method investments | (7444) | —  | (7444) |  |  |
| Income tax on items above and discrete tax items | (1941) | —  | (1941) |  |  |
| NCI impact of items above | —  | (1360) | (1360) |  |  |
| **Adjusted (Non-GAAP)** | $**39683**  | $**(6607)** | $**33076**  |  | $**0.35**  |
| **Weighted average shares outstanding – diluted** |  |  | 95677  |  |  |

---

------

**Supplemental Reconciliation of Prior Year Segment Results to Current Year Segment Results – Unaudited**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** |
| | **March 31, 2025** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **March 31, 2026** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $878145  | $—  | $—  | $59515  | $937660  |
| Diversified Fresh Produce - EMEA | 892087  | 94584  | —  | 35653  | 1022324  |
| Diversified Fresh Produce - Americas & ROW | 363413  | 1601  | —  | 54997  | 420011  |
| Intersegment | (34241) | —  | —  | (3579) | (37820) |
| **Total** | $2099404  | $96185  | $—  | $146586  | $2342175  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** |
| | **March 31, 2025** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **March 31, 2026** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $63331  | $(462) | $—  | $(10316) | $52553  |
| Diversified Fresh Produce - EMEA | 27660  | 3665  | 46  | (1406) | 29965  |
| Diversified Fresh Produce - Americas & ROW | 13831  | (44) | —  | 4007  | 17794  |
| **Total** | $104822  | $3159  | $46  | $(7715) | $100312  |

---

------

**Net Debt and Net Leverage Reconciliation – Unaudited**

Net Debt is the primary measure used by management to analyze the Company's capital structure. Net Debt is a non-GAAP financial measure, calculated as cash and cash equivalents, less current and long-term debt. It also excludes debt discounts and debt issuance costs. Net Leverage is calculated as total Net Debt divided by Last Twelve Months ("LTM") Adjusted EBITDA as of the period end. The calculation of Net Debt and Net Leverage as of March 31, 2026 is presented below. Net Debt as of March 31, 2026 was $657.1 million and Net Leverage was 1.7x.

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Cash and cash equivalents (Reported GAAP) | $273168  | $267854  |
| Debt (Reported GAAP): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | (870176) | (799814) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities | (40633) | (57668) |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank overdrafts | (12696) | (9611) |
| Total debt, net | (923505) | (867093) |
| Add: Debt discounts and debt issuance costs (Reported GAAP) | (6790) | (7237) |
| Total gross debt | (930295) | (874330) |
| **Net Debt (Non-GAAP)** | $(657127) | $(606476) |
| LTM Adjusted EBITDA (Non-GAAP) | 390866  | 395376  |
| **Net Leverage (Non-GAAP)** | **1.7x** | **1.5x** |
| **Last Twelve Months ("LTM") Adjusted EBITDA** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FY'25 Adjusted EBITDA | 395376  | 395376  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Q1'25 YTD Adjusted EBITDA | (104822) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Q1'26 YTD Adjusted EBITDA | 100312  |  |
| **LTM Adjusted EBITDA** | $390866  | $395376  |

---

**Free Cash Flow from Continuing Operations Reconciliation – Unaudited**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31, 2026** | **March 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Net cash provided by operating activities - continuing operations (Reported GAAP) | $(22467) | $(78789) |
| Less: Capital expenditures (Reported GAAP)<sup>5</sup> | (17758) | (52836) |
| **Free cash flow from continuing operations (Non-GAAP)** | $(40225) | $(131625) |

---

<sup>5</sup> Capital expenditures do not include amounts attributable to discontinued operations.

------

**Non-GAAP Financial Measures**

Dole plc's results are determined in accordance with U.S. GAAP.

In addition to its results under U.S. GAAP, in this Press Release, we also present Dole plc's Adjusted EBIT, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow from Continuing Operations, Net Debt and Net Leverage, which are supplemental measures of financial performance that are not required by, or presented in accordance with, U.S. GAAP (collectively, the "non-GAAP financial measures"). We present these non-GAAP financial measures, because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. These non-GAAP financial measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our operating results, cash flows or any other measure prescribed by U.S. GAAP. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by any of the adjusted items or that any projections and estimates will be realized in their entirety or at all. In addition, adjustment items that are excluded from non-GAAP results can have a material impact on equivalent GAAP earnings, financial measures and cash flows.

Adjusted EBIT is calculated from GAAP net income by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (5) other items which are separately stated based on materiality, which during the three months ended March 31, 2026 and March 31, 2025, included subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property or sales-type leases, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, subtracting interest income on deferred transaction consideration, adding acquisition and transaction costs and adding restructuring charges and costs for legal matters not in the ordinary course of business; and (6) the Company's share of these items from equity method investments.

Adjusted EBITDA is calculated from GAAP net income by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding depreciation charges; (5) adding amortization charges on intangible assets; (6) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (7) other items which are separately stated based on materiality, which during the three months ended March 31, 2026 and March 31, 2025, included subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property or sales-type leases, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, subtracting interest income on deferred transaction consideration, adding acquisition and transaction costs and adding restructuring charges and costs for legal matters not in the ordinary course of business; and (8) the Company's share of these items from equity method investments.

Last Twelve Months ("LTM") Adjusted EBITDA is calculated as Adjusted EBITDA, as defined above, for the last twelve months as of the period end, which for the three months ended March 31, 2026, is calculated as subtracting the Adjusted EBITDA for the three months ended March 31, 2025 from the Adjusted EBITDA for the year ended December 31, 2025 and then adding Adjusted EBITDA for the three months ended March 31, 2026. LTM Adjusted EBITDA for the year ended December 31, 2025 is the same as Adjusted EBITDA for the year ended December 31, 2025.

Adjusted Net Income is calculated from GAAP net income attributable to Dole plc by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding amortization charges on intangible assets; (3) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (4) other items which are separately stated based on materiality, which during the three months ended March 31, 2026 and March 31, 2025, included subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property or sales-type leases, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, adding acquisition and transaction costs and adding restructuring charges and costs for legal matters not in the ordinary course of business; (5) the Company's share of these items from equity method investments; (6) excluding the tax effect of these items and discrete tax adjustments; and (7) excluding the effect of these items attributable to non-controlling interests.

Adjusted Earnings per Share is calculated from Adjusted Net Income divided by diluted weighted average number of shares in the applicable period.

Net Debt is a non-GAAP financial measure, calculated as GAAP cash and cash equivalents, less GAAP current and long-term debt. It also excludes GAAP unamortized debt discounts and debt issuance costs.

Net Leverage is a non-GAAP financial measure, calculated as Net Debt divided by LTM Adjusted EBITDA, both of which are defined above.

Free cash flow from continuing operations is calculated from GAAP net cash used in or provided by operating activities for continuing operations less GAAP capital expenditures.

Like-for-like basis refers to the U.S. GAAP measure or non-GAAP financial measure excluding the impact of foreign currency translation movements and acquisitions and divestitures. The impact of foreign currency translation represents an estimate of the effect of translating the results of operations denominated in a foreign currency to U.S. Dollar at prior year average rates, as compared to current year average rates.

Dole is not able to provide a reconciliation for projected FY'26 results without taking unreasonable efforts.